Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution. Researchers ...
Lipid nanoparticles (LNPs) act as carriers for mRNA and CRISPR payloads across a wide range of therapeutic applications, from cancer to inflammatory and genetic diseases. The same delivery system used ...
A trio of common amino acids may hold the key to unlocking far more powerful gene therapies. Researchers found that adding them to lipid nanoparticles can boost mRNA delivery up to 20-fold and push ...
Simple ‘cocktail’ of amino acids dramatically boosts power of mRNA therapies and CRISPR gene editing
Artist's rendering of a lipid nanoparticle (blue spherical shape at left) supplemented by amino acids (depicted as chemical compounds) fusing with the cell membrane (red) to deliver therapeutic cargo ...
Lipid nanoparticles (LNPs) are a popular platform for emerging gene editing and other cell-based therapies. Despite how well these miniscule vehicles transport their genetic cargo to cells in vitro, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results